Advanced in Congenital Athymia
Advanced in Congenital Athymia

Overview

Kenneth Heym is a Pediatrics provider in Fort Worth, Texas. Dr. Heym is rated as an Advanced provider by MediFind in the treatment of Congenital Athymia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Reticulohistiocytoma.

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 23 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Vanderbilt University (1999)
Residency
Children's Hospital of NY - Presbyterian (2002)
Specialties
Pediatrics
Licenses
Pediatric Hematology-Oncology in TX
Fellowships
Baylor COM at Houston - Urology (2005)
Hospital Affiliations
Texas Health Fort Worth
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
FirstCare
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 15 Less Insurance Carriers -

Locations

Cook Children's Medical Center-Dept of Hematology & Oncology
1500 Cooper St, 5th Fl, Fort Worth, TX 76104

Additional Areas of Focus

Dr. Heym has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


23 Clinical Trials

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Phase II Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
View 22 Less Clinical Trials
Similar Doctors
Advanced in Congenital Athymia
Developmental and Behavioral Pediatrics | Pediatrics
Advanced in Congenital Athymia
Developmental and Behavioral Pediatrics | Pediatrics

Texas Scottish Rite Hospital For Children

2222 Welborn St, 
Dallas, TX 
 (31.0 miles away)
Experience:
12+ years
Languages Spoken:
English

Shanmuga Jonnalagadda is a Developmental and Behavioral Pediatrics specialist and a Pediatrics provider in Dallas, Texas. Dr. Jonnalagadda has been practicing medicine for over 12 years and is rated as an Advanced provider by MediFind in the treatment of Congenital Athymia. Her top areas of expertise are Delayed Growth, Developmental Dysphasia Familial, Autism Spectrum Disorder, and Gastroschisis.

Advanced in Congenital Athymia
Advanced in Congenital Athymia
855 Montgomery St, 
Fort Worth, TX 
 (1.8 miles away)
Languages Spoken:
English, Spanish
Accepting New Patients

Taina Trevino is a Pediatrics provider in Fort Worth, Texas. Dr. Trevino is rated as an Advanced provider by MediFind in the treatment of Congenital Athymia. Her top areas of expertise are Obesity in Children, Congenital Athymia, Autism Spectrum Disorder, and Croup. Dr. Trevino is currently accepting new patients.

Experienced in Congenital Athymia
Neonatology | Pediatrics
Experienced in Congenital Athymia
Neonatology | Pediatrics

Pediatrix Medical Group - Neonatology

801 7th Ave, 
Fort Worth, TX 
 (0.1 miles away)
Languages Spoken:
English

Mary Lynch is a Neonatologist and a Pediatrics provider in Fort Worth, Texas. Dr. Lynch is rated as an Advanced provider by MediFind in the treatment of Congenital Athymia. Her top areas of expertise are Atresia of Small Intestine, Gastroschisis, Congenital Athymia, and Patent Ductus Arteriosus.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Heym's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile